Dosimetry of high-dose treatment with 131I in differentiated thyroid cancer -: Evaluation by PET and 124I.

被引：0
|
作者：
Eschmann, SM
Thelen, MH
Reischl, G
Zagar, I
Dohmen, BM
Coenen, HH
Machulla, HJ
Bares, R
机构：
[1] Res Ctr Julich, Julich, Germany
[2] Univ Belgrade, Belgrade, Yugoslavia
[3] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
333
引用
收藏
页码：84P / 84P
页数：1
相关论文
共 50 条
  • [41] Usefulness of 124I PET/CT for 131I treatment planning in patients affected by metastatic thyroid cancer: Preliminary results
    Pettinato, Cinzia
    Monari, Fabio
    Civollani, Simona
    Allegri, Vincenzo
    Marcatili, Sara
    Cima, Simona
    Spezi, Emiliano
    Mazzarotto, Renzo
    Marengo, Mario
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [42] Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities
    Ruhlmann, Marcus
    Sonnenschein, Wilfried
    Nagarajah, James
    Binse, Ina
    Herrmann, Ken
    Jentzen, Walter
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (05) : 457 - 464
  • [43] Evaluation of the Efficiency of 131I Ablative Dose of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Ben Sellem, D.
    Kraiem, T.
    Letaief, B.
    Ben Slimene, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S348 - S349
  • [44] Absolute Recovery Coefficients in 124I PET/CT Imaging in 131I Radioiodine Therapy of Thyroid Cancer
    Pigotti, G.
    Martini, D.
    Villano, C.
    De Francesco, V.
    Baldassarrini, E.
    Panichelli, P.
    Valentini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S253 - S253
  • [45] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications
    Piotr Szumowski
    Saeid Abdelrazek
    Dorota Iwanicka
    Małgorzata Mojsak
    Monika Sykała
    Łukasz Żukowski
    Katarzyna Siewko
    Agnieszka Adamska
    Katarzyna Maliszewska
    Anna Popławska-Kita
    Małgorzata Szelachowska
    Adam Krętowski
    Janusz Myśliwiec
    Scientific Reports, 11
  • [46] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications
    Szumowski, Piotr
    Abdelrazek, Saeid
    Iwanicka, Dorota
    Mojsak, Malgorzata
    Sykala, Monika
    Zukowski, Lukasz
    Siewko, Katarzyna
    Adamska, Agnieszka
    Maliszewska, Katarzyna
    Poplawska-Kita, Anna
    Szelachowska, Malgorzata
    Kretowski, Adam
    Mysliwiec, Janusz
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response
    Plyku, Donika
    Hobbs, Robert F.
    Wu, Di
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (03) : 213 - 223
  • [48] Critical evaluation of 131I SPECT/CT imaging in differentiated thyroid cancer management
    Kumar, Abhishek
    Kundu, Parveen
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [49] I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response
    Donika Plyku
    Robert F. Hobbs
    Di Wu
    Carlos Garcia
    George Sgouros
    Douglas Van Nostrand
    Annals of Nuclear Medicine, 2022, 36 : 213 - 223
  • [50] Dosimetry based high dose I-131 therapy for thyroid cancer
    Menda, Yusuf
    Madsen, Mark
    Bushnell, David
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345